Please login to the form below

Not currently logged in


This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.

Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate

It then anticipates launches expected in France, Germany and UK by the end of the year, with launches in Spain and Italy  to follow in 2020.

Latest news

More from news
Approximately 43 fully matching, plus 820 partially matching documents found.

Latest Intelligence

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    The HTA file is in a difficult situation at the moment with Germany and France blocking it. ... For smaller companies however, the stakes are higher. If France, Germany and a few other countries want to support innovation and faster market uptake up to

  • Is anybody listening? Is anybody listening?

    Similarly, authorities in Germany, China, Russia and Australia – as well as the EU in general – are all taking measures to clamp down on companies that aren’t doing enough to fulfil

  • Bluebird: on a mission to ‘recode’ the DNA of healthcare Bluebird: on a mission to ‘recode’ the DNA of healthcare

    Bluebird is focusing on Germany, Italy, France and the UK as its initial launch markets, as 90% of Europe’s beta thalassemia patients live in these four countries. ... He said conversations with Germany’s sick funds have been constructive so far, not

  • The Orkambi row explained The Orkambi row explained

    Germany granted very rapid approval after launch, and Ireland – which has the highest per capita incidence of CF – agreed a portfolio deal in April 2017.

  • #OrkambiNow? #OrkambiNow?

    For example in Germany, from the time of European licensing, adults and children of 12 and over were able to access Orkambi if they had the right mutations.”.

More from intelligence
Approximately 9 fully matching, plus 120 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 73 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 69 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....